Short communication · 1 Apr 2021
Conference abstractPublished 2019
Transfusion in Oncology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cancer patients often have hematological disorders, and can affect erythrocytes, platelets, leukocytes or blood proteins. Therefore, transfusion support is essential in the treatment of oncological patients. However, blood transfusion is not riskfree and some complications may appear, mostly mild, and some serious, but they can lead to death. Indeed, even oncologic patients can develop alloimmune or autoimmune processes during the transfusion support of their treatments. Alloimmunization is a significant risk of transfusions and is the second leading cause of transfusion-associated death. Despite the high degree of immunosuppression (both by the basic disease itself and the drugs used in its treatment), oncologic patients can still mount an immune response to erythrocyte antigens, platelets or leukocyte foreign. Hospitalized patients may present autoantibodies against blood cells. When the immune system is involved, an autoimmune hemolytic anemia, autoimmune thrombocytopenia or more rarely neutropenia may appear. The autoimmune haemolytic anaemia may be produced by cold and warm autoantibodies and may mediate intravascular or extravascular autoimmune haemolysis in oncology patients. A better understanding of testing realized in the immunohematology laboratory will allow oncology providers to make informed decisions on the risk/benefit ratio of transfusion for their individual patients. Further, this understanding will allow improved communication between oncology providers and the transfusion Service in instances of transfusion histories, new antibody formation, and unexpected adverse transfusion sequelae.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 10 Jan 2019
Survey of thalassemia major patients receiving regular blood transfusion at day care oncology of a tertiary care hospital in Karachi, Pakistan
Conference abstract · 2019
HLA matching at epitope level: an effective approach to provide platelet transfusion support in platelet refractory patients in a tertiary care oncology centre
Conference abstract · 14 Sep 2016
Blood transfusion is associated with adverse outcomes in pediatric oncology patients following tumor resection
Research article · 4 Jan 2019
Implementation of a restrictive blood transfusion protocol in a gynecologic oncology service
More from this journal
The newest in Archives in Cancer Research.
Perspective · 20 Dec 2024
Radiotherapy: Advances, Mechanisms, and Applications in Cancer Treatment
Perspective · 20 Dec 2024
Chemotherapy: A Vital Treatment in the Battle Against Cancer
Perspective · 20 Dec 2024
Tumor Microenvironment: A Key Determinant of Cancer Progression
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives in Cancer Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Carlos A Gonzalez”

